HYHongmei Yin

Hongmei Yin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hongmei Yin has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Chaomang Zhu

    Department of Radiotherapy, First Affiliated Hospital of Bengbu Medical College, Bengbu, China

    1 shared publication
  • Duojie Li

    Department of Radiotherapy, First Affiliated Hospital of Bengbu Medical College, Bengbu, China

    1 shared publication
  • Jia Chen

    Department of Environmental Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA

    1 shared publication
  • Mingxi Wang

    Department of Oncology, First Affiliated Hospital of Bengbu Medical College, Bengbu, China

    1 shared publication
  • Nannan Wei

    Department of Radiotherapy, First Affiliated Hospital of Bengbu Medical College, Bengbu, China

    1 shared publication
  • Qiong He

    Pathology Department Fudan University Shanghai Cancer Center Shanghai China

    1 shared publication

Latest Publications

  • Open Access

    Drug metabolism‐related eight‐gene signature can predict the prognosis of gastric adenocarcinoma

    by Hong‐Mei Yin, Qiong He, Jia Chen, Zhen Li, Wanli Yang, Xiaobo Hu

    Background: Metabolic abnormalities in patients with gastric adenocarcinoma lead to drug resistance and poor prognosis. Therefore, this study aimed to explore biomarkers that can predict the prognostic risk of gastric adenocarcinoma by analyzing drug metabolism‐related genes.Methods: The RNA‐seq and clinical information on gastric adenocarcinoma were downloaded from the UCSC and gene expression omnibus databases. Univariate and least absolute shrinkage and selection operator regression analyses were used to identify the prognostic gene signature of gastric adenocarcinoma. The relationships between gastric adenocarcinoma prognostic risk and tumor microenvironment were assessed using CIBERSORT, EPIC, QUANTISEQ, MCPCounter, xCell, and TIMER algorithms. The potential drugs that could target the gene signatures were predicted in WebGestalt, and molecular docking analysis verified their binding stabilities.Results: Combined with clinical information, an eight‐gene signature, includingGPX3,ABCA1,NNMT,NOS3,SLCO4A1,ADH4,DHRS7, andTAP1, was identified from the drug metabolism‐related gene set. Based on their expressions, risk scores were calculated, and patients were divided into high‐ and low‐risk groups, which had significant differences in survival status and immune infiltrations. Risk group was also identified as an independent prognostic factor of gastric adenocarcinoma, and the established prognostic and nomogram models exhibited excellent capacities for predicting prognosis. Finally, miconazole and niacin were predicted as potential therapeutic drugs for gastric adenocarcinoma that bond stably withNOS3andNNMTthrough hydrogen interactions.Conclusions: This study proposed a drug metabolism‐related eight‐gene signature as a potential biomarker to predict the gastric adenocarcinoma prognosis risks.


  • Open Access

    Factors relevant to the prognosis of patients with esophageal cancer who received intensity‐modulated radiotherapy

    by Hongmei Yin, Duojie Li, Chaomang Zhu, Mingxi Wang, Nannan Wei

    Background: The aim of this study was to evaluate the clinical factors relevant to the prognosis of patients with esophageal cancer who received intensity‐modulated radiotherapy (IMRT).Methods: The data of 60 patients admitted to our hospital from January 2014 to December 2015 with pathologically confirmed esophageal cancer were retrospectively reviewed. All patients received IMRT. Patients were divided into groups according to two‐year survival: those who survived > 2 years after treatment, and those who died within 2 years of treatment. The potential clinical factors relevant to prognosis were evaluated by logistic regression analysis.Results: Single factor analysis showed that lesion length (P < 0.05), tumor diameter (P < 0.05), T stage (P < 0.05), N stage (P < 0.05), and combined chemotherapy (P < 0.05) were associated with the prognosis of esophageal cancer patients who received IMRT. Logistic regression analysis demonstrated that T stage (odds ratio = 3.62; P < 0.05) and N stage (odds ratio = 2.98; P < 0.05) were independent factors relevant to prognosis.Conclusion: T stage and N stage influence the long‐term curative effects of IMRT for esophageal cancer. The higher the stage, the lower the two‐year survival rate.